entertainment -WSS

entertainment

author：leisure time 2025-09-30 08:49:43 - browse：178

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Rep. Raul Ruiz on the physician shortage and more

entertainment

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

CDC director unscathed in first congressional testimony

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Many immigrants are left out of maternal health programs

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Teacher posts viral 'school supply rant' with advice for parents

focus

entertainment

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Doctors increasingly discourage vaping amid mounting health concerns

Wildfire smoke exposes gaps in outdoor worker protections

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

New air purifier tech could be key to improving indoor air quality

What AstraZeneca

Hollywood unions extend contract negotiations for actors

As biotech industry slumps, bioscience job market is upside down

Hepatitis C has a cure — but many Americans still lack access to it

30 years of 'Listening to Prozac'

focus

Diagnostic tests are hitting their mathematical limits

Russian and Belarusian players banned from a women's tennis tournament in Prague

What AstraZeneca

What AstraZeneca

CDC director unscathed in first congressional testimony

Europe is fastest

hotspot

entertainment

leisure time

hotspot